跳至主要内容
临床试验/IRCT20220205053945N1
IRCT20220205053945N1尚未招募3 期

Evaluation of the effect of probiotic supplements as adjunctive therapy in improving the symptoms of psychosis, anxiety, insomnia and anorexia due to amphetamine and methamphetamine use. A double-blind randomized placebo-controlled clinical trial at Imam Hossein Hospital

Alborz university of medical sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Positive amphetamine and methamphetamine test
  • Diagnosis of amphetamine use disorder based on DSM5 criteria after interview with psychiatrist
  • Voluntary organization of the individual and his / her guardian to participate in the project
  • Age: 18 to 60 years old
  • IQ above 70
  • Not receiving to receive electroshock in the last two weeks
  • Do not use other drugs (all opioids, morphine and methadone and marijuana are taken from the patient during the evaluation - testing of urinary toxic acid for amphetamine and methamphetamine)
  • Lack of other psychiatric disorders such as schizophrenia Bipolar disorder Depression with psychosis

排除标准

  • Prominent neurological or organic disease and cardiovascular disease and history of cardiac surgery or any cardiovascular procedure, clinical and laboratory examinations and review of family history and records
  • Another diagnosis in Axis I based on DSM-V
  • IQ less than 70 based on clinician clinical suspicion
  • Abusing of other substances (except nicotine and caffeine)
  • Taking oral antipsychotics in the past week or long-acting antipsychotics in the past month
  • Receiving ECT in the last two weeks
  • Women of childbearing age will not be accepted without adequate methods of contraception
  • CHF and liver disease

研究者

发起方
Alborz university of medical sciences

相似试验